Company: SCLXW
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047800
Chunk: 48

Company: Scilex Holding Co
Filing Date: 2025-03-31
Form: 10-K
Item: Item 7
Chunk 48
---
 Purchase Agreement (as defined below), the Revolving Facility, the issuance of the Convertible Debentures and financing pursuant to the ATM Sales Agreement (as defined below). We also have indebtedness pursuant to the Oramed Note and Tranche B Notes as well as deferred consideration related to the GLOPERBA license acquired from Romeg in 2022. The following table summarizes the aggregate indebtedness of these issuances as of December 31, 2024 and December 31, 2023 (in thousands):

 129

    December 31, 2024

    December 31, 2023

    Oramed Note (outstanding principal balance: $25.0 million and $100.9 million as of December 31, 2024 and 2023, respectively)
     
    $
    12,161

    $
    104,089

    Convertible Debentures (outstanding principal balance: nil and $4.4 million as of December 31, 2024 and 2023, respectively)

    —

    4,340

    Tranche B Notes (outstanding principal balance: $38.0 million and nil as of December 31, 2024 and 2023, respectively)

    23,560

    —

    Purchased Revenue Liability

    6,800

    —

    Revolving Facility

    —

    17,038

    Deferred Consideration with Romeg

    2,895

    3,386

    Total indebtedness
     
    $
    45,416

    $
    128,853

The Oramed Note

As of December 31, 2024, the fair value of the Oramed Note outstanding was $12.2 million pursuant to the Scilex-Oramed SPA (see Note 7 titled “Debt” to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for additional information).

Convertible Debentures

We fully repaid the Convertible Debentures in March 2024 (see Note 7 titled “Debt” to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for additional information).

Tranche B Notes

As of December 31, 2024, the fair value of the Tranche B Notes outstanding was $23.6 million pursuant to the Tranche B Securities Purchase Agreement (see Note 7 titled “Debt” to our